316
Views
5
CrossRef citations to date
0
Altmetric
BASIC REVIEW

The New Genetics and Chronic Obstructive Pulmonary Disease

&
Pages 257-264 | Published online: 02 Jul 2009

REFERENCES

  • Pauwels R A, Rabe K F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364(9434)613–620
  • Wouters E F. Management of severe COPD. Lancet 2004; 364(9437)883–895
  • Barnes P J, Shapiro S D, Pauwels R A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22(4)672–688
  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1(6077)1645–1648
  • Rennard S I, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006; 367(9518)1216–1219
  • Silverman E K, Chapman H A, Drazen J M, Weiss S T, Rosner B, Campbell E J, O'Donnell W J, Reilly J J, Ginns L, Mentzer S, Wain J, Speizer F E. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1770–1778
  • McCloskey S C, Patel B D, Hinchliffe S J, Reid E D, Wareham N J, Lomas D A. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001; 164: 1419–1424
  • Redline S, Tishler P V, Rosner B, Lewatter F I, Vandenburgh M, Weiss S T, Speizer F E. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989; 129(4)827–836
  • Kueppers F, Miller R D, Gordon H, Hepper N G, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977; 63(3)330–42
  • Lomas D A, Silverman E K. The genetics of chronic obstructive pulmonary disease. Respir Res 2001; 2(1)20–26
  • De Meo D L, Silverman E K. Genetics of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2003; 24(2)151–160
  • Hautamaki R D, Kobayashi D K, Senior R M, Shapiro S D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277(5334)2002–2004
  • Morris D G, Huang X, Kaminski N, Wang Y, Shapiro S D, Dolganov G, Glick A, Sheppard D. Loss of integrin Alpha (v) β 6 –mediated TGF-β activation causes Mmp-12-dependent emphysema. Nature 2003; 422(6928)169–173
  • Silverman E K, Pierce J A, Province M A, Rao D C, Campbell E J. Variability of pulmonary function in alpha 1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989; 111: 982–991
  • Hersh C P, Dahl M, Ly N P, Berkey C S, Nordestgaard B G, Silverman E K. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004; 59(10)843–849
  • The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437(7063)1299–1320
  • Todd J A, Walker N M, Cooper J D, Smyth D J, Downes K, Plagnol B, Bailey R, Nejentsev S, Field S F, Payne F, Lowe C E, Szeszko J F, Hafler J P, Zeitels L, Yang J H, Vella A, Nutland S, Stevens H E, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink L J, Healy B, Burren O S, Lam A A, Ovington O R, Halem J, Allen J, Adlem D, Leung H T, Wallace C, Howson J M, Guja C, Ionescu -Tirgoviste C, Simmonds M J, Heward J M, Gough S C, Dunger D B, Wicker L S, Clayton D G. Robust associations of four new chromosome regions from genome- wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857–864
  • Silverman E K, Palmer L J, Mosley J D, Barth M, Senter J M, Brown A, Drazen J M, Kwiatkowski D J, Chapman H A, Campbell E J, et al. Genome-wide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70: 1229–1239
  • Palmer L J, Celedon J C, Chapman H A, Speizer F E, Weiss S T, Silverman E K. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12: 1199–1210
  • The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447(7145)661–678
  • Chappell S, Daly L, Morgan K, Guetta Baranes T, Roca J, Rabinovich R, Millar A, Donnelly S C, Keatings V, MacNee W, Stolk J, Hiemstra P, Miniati M, Monti S, O'Connor C M, Kalsheker N. Cryptic haplotypes of SERPIN A1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 2006; 27(1)103–109
  • Demeo D L, Maniari T J, Lange C, Srisuma S, Litonjua A A, Celedon J C, Lake S L, Reilly J J, Chapman H A, Mecham B H, Haley K J, Sylvia J S, Sparrow D, Spira A E, Beane J, Pinto-Plata V, Speizer F E, Shapiro S D, Weiss S T, Silverman E K. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 2006; 78(2)253–264
  • Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson W H, Lomas D A, Silverman E K, Pillai S G. International COPD Genetics Network (ICGN) Investigators. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007; 176(2)167–173
  • Chappell S, Daly L, Morgan K, Guetta Baranes T G, Roca J, Robinovitch R, Millar A, Donnelly S C, Keatings V, MacNee W, Stolk J, Hiemstra P, Miniati M, Monti S, O'Connor C M, Kalsheker N. The SERPIN E2 gene and chronic obstructive pulmonary disease. Am J Hum Genet 2006; 79(1)184–186
  • Hirschorn J N, Daly M J. Genome-wide association studies for common diseases and complex traits. Nature Rev Genet 2005; 6: 95–108
  • Wang W YS, Barratt B J, Clayton D G, Todd J A. Genome-wide association studies: theoretical and practical considerations. Nature Rev Genet 2005; 6: 109–118
  • Drumm M L, Konstan M W, Schluchter M D, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn J M, Darrah R J, Dorfman R, Sandford A J, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas J R, Wright F A, Knowles M R, Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353(14)1443–1453
  • Graham R R, Kozyrev S V, Baechler E C, Reddy M V, Plenge R M, Bauer J W, Ortmann W A, Koeuth T, González Escribano M F, Argentine and Spanish Collaborative Groups, Pons-Estel B, Petri M, Daly M, Gregersen P K, Martín J, Altshuler D, Behrens T W, Alarcón-Riquelme M E. A common haplotype of interferon regulatory factor 5 (IRF 5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38(5)550–555
  • Smyth D J, Cooper J D, Bailey R, Field S, Burren O, Smink L J, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger D B, Savage D A, Walker N M, Clayton D G, Todd J A. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IF1H) region. Nat Genet 2006; 38(6)617–619
  • Grant S F, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson K P, Walters G B, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky R L, Reilly M P, Rader D J, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher J R, Kong A, Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38(3)320–323
  • Florez J C, Jablonski K A, Bayley N, Pollin T I, de Bakker P I, Shuldiner A R, Knowler W C, Nathan D M, Altshuler D, Diabetes Prevention Program Research Group. TCf7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355(3)241–250
  • Segre D, Deluna A, Church G M, Kishony R. Molecular epistasis in yeast metabolism. Nat Genet 2005; 37(1)77–83
  • Redon R, Ishikawa S, Fitch K R, Feuk A, Perry G H, Andrews T D, Fiegler H, Shapero M H, Carson A R, Chen W, Cho E K, Dallaire S, Freeman J L, González J R, Gratacòs M, Huang J, Kalaitzopoulos D, Komura D, MacDonald J R, Marshall C R, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville M J, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Zhang J, Armengol L, Conrad D F, Estivill X, Tyler-Smith C, Carter N P, Aburatani H, Lee C, Jones K W, Scherer S W, Hurles M E. Global variation in copy number in the human genome. Nat Genet 2006; 444(7118)444–454
  • Marchini J, Donnelly P, Cardon L R. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005; 37(4)413–417
  • Skol A D, Scott L J, Abecasis G R, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome wide association studies. Nat Genet 2006; 38(2)209–213
  • de Bakker P I, Yelensky R, Pe'er I, Gabriel S B, Daly M J, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37(11)1217–1223
  • Complexity, Entropy and the Physics of Information, W H Zurek. Addison-Wesley, Redwood City, California 1990; 73–89
  • Willbrand K, Radvanyi F, Nadal J P, Thiery J P, Fink T M. Identifying genes from up-down properties of microarray expression series. Bioinformatics 2005; 21(20)3859–3864
  • He J Q, Connett J E, Anthonisen N R, Pare P D, Sandford A J. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004; 170(4)388–394
  • Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(8)693–696
  • Joos L, He J Q, Shepherdson M B, Connett J E, Anthonisen N R, Paré P D, Sandford A J. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11(5)569–576
  • Guo X, Lin H M, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18(3)482–490
  • Sakao S, Tatsumi K, Iqari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumour necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Care Med 2001; 163(2)420–422
  • Smith C AD, Harrison D J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350(9078)630–633
  • Sandford A J, Chagani T, Weir T D, Connett J E, Anthonisen N R, Pare P D. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163(2)469–473

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.